We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$8.38B
AUM Growth
+$1.92B
(+30%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
18.83%
Top 10 Holdings %
Top 10 Hldgs %
13.01%
Holding
3,099
New
763
Increased
795
Reduced
700
Closed
736
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$77.6M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$71.2M |
| 3 |
Microsoft
MSFT
|
+$70M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$67.5M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$61.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 2 |
Colgate-Palmolive
CL
|
+$33.1M |
| 3 |
Phillips 66
PSX
|
+$31.7M |
| 4 |
S&P Global
SPGI
|
+$27.7M |
| 5 |
VMW
VMware, Inc
VMW
|
+$22.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.29% |
| 2 | Healthcare | 9.42% |
| 3 | Industrials | 9.09% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Financials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
2276
Kyntra Bio
KYNB
$28.7M
| $131K | ﹤0.01% |
1,948
-52
| -3% | -$21.5K |
|
2277
Scholar Rock
SRRK
$6.55B
| $131K | ﹤0.01% |
17,422
+4,082
| +31% | +$30.8K |
|
2278
Akebia Therapeutics
AKBA
$248M
| $130K | ﹤0.01% |
142,274
| – | – |
|
2279
Nurix Therapeutics
NRIX
$2.76B
| $130K | ﹤0.01% |
12,991
-9,115
| -41% | -$93K |
|
2280
Design Therapeutics
DSGN
$917M
| $130K | ﹤0.01% |
20,561
-7,078
| -26% | -$43.3K |
|
2281
Cato Corp
CATO
$65.7M
| $126K | ﹤0.01% |
15,750
-18,415
| -54% | -$153K |
|
2282
Definitive Healthcare
DH
$69.4M
| $124K | ﹤0.01% |
11,309
-93,214
| -89% | -$960K |
|
2283
Kearny Financial
KRNY
$600M
| $121K | ﹤0.01% |
17,115
-39,747
| -70% | -$295K |
|
2284
Blend Labs
BLND
$331M
| $120K | ﹤0.01% |
126,767
-29,448
| -19% | -$26.1K |
|
2285
AbCellera Biologics
ABCL
$3.18B
| $118K | ﹤0.01% |
18,247
+175
| +1% | +$1.19K |
|
|
BGRY
2286
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $117K | ﹤0.01% |
83,139
| – | – |
|
|
AXDX
2287
DELISTED
Accelerate Diagnostics
AXDX
| $114K | ﹤0.01% |
14,114
| – | – |
|
2288
SGHC Ltd
SGHC
$6.51B
| $112K | ﹤0.01% |
38,751
| – | – |
|
2289
Lexicon Pharmaceuticals
LXRX
$1.05B
| $111K | ﹤0.01% |
48,585
+37,585
| +342% | +$99.8K |
|
2290
Kodiak Sciences
KOD
$2.72B
| $111K | ﹤0.01% |
+16,027
| New | +$98K |
|
|
IGMS
2291
DELISTED
IGM Biosciences
IGMS
| $105K | ﹤0.01% |
11,341
-3,156
| -22% | -$35.4K |
|
|
NGM
2292
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $103K | ﹤0.01% |
39,953
| – | – |
|
2293
Q32 Bio
QTTB
$458M
| $102K | ﹤0.01% |
6,424
| – | – |
|
|
ESPR
2294
DELISTED
Esperion Therapeutics
ESPR
| $101K | ﹤0.01% |
72,525
-49,456
| -41% | -$69.1K |
|
2295
ADMA Biologics
ADMA
$2.19B
| $99.5K | ﹤0.01% |
+26,952
| New | +$99.9K |
|
2296
Fossil Group
FOSL
$311M
| $97.6K | ﹤0.01% |
37,987
-91,293
| -71% | -$251K |
|
2297
Valens Semiconductor
VLN
$202M
| $97.2K | ﹤0.01% |
38,426
-23,327
| -38% | -$59.3K |
|
|
TUP
2298
DELISTED
Tupperware Brands Corporation
TUP
| $95.9K | ﹤0.01% |
119,906
-3,073
| -2% | -$3.33K |
|
2299
Novavax
NVAX
$1.31B
| $91.3K | ﹤0.01% |
+12,289
| New | +$96.6K |
|
|
MCHB
2300
Mechanics Bancorp
MCHB
$3.8B
| $88.4K | ﹤0.01% |
14,935
-16,056
| -52% | -$151K |
|
Similar funds
SCP
Tudor Investment Corp's Q2 2023 Portfolio in Review
As of Q2 2023, Tudor Investment Corp held 3,099 positions worth $8.38B, up 30% from $6.46B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Tudor Investment Corp deployed $1.58B of net new capital in Q2 2023, opening 763 new positions and adding to 795 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 340,004 shares worth $65.4M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Colgate-Palmolive, an estimated $33.1M trimmed.
- Tudor Investment Corp's largest Q2 2023 buy was Seagen Inc. Common Stock: 340,004 shares worth $65.4M.
- Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $77.6M increase.
- Tudor Investment Corp's biggest Q2 2023 reduction was Colgate-Palmolive, cutting an estimated $33.1M.
- Tudor Investment Corp fully exited Johnson & Johnson in Q2 2023, selling an estimated $34.9M.
- Tudor Investment Corp's ten largest holdings make up 13% of its $8.38B portfolio in Q2 2023.
- Tudor Investment Corp opened 763 new positions and closed 736 in Q2 2023.
- Tudor Investment Corp's portfolio value rose 30% quarter-over-quarter to $8.38B.
Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.